About Endocare
Endocare is a Healthcare company based in Austin (United States) founded in 1996, and was acquired by Varian Medical Systems in June 2019. Cancer diagnostic and therapeutic instruments are provided by Endocare. Endocare has raised $38.6 million across 3 funding rounds from investors including Varian and Frazier Healthcare Partners. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity is ENDOCARE INC. Its competitors include Guardant Health, Denali Therapeutics and Foundation Medicine; 3 of its 3 listed competitors have raised funding.
Company details
Endocare was founded in 1996 in Austin, United States, and operates within the medical device sector focused on oncology. Diagnostic tools, including an integrated biplane ultrasound for tumor detection via color Doppler visualization, are offered alongside surgical instruments for cryopreservation of cancer cells and planning software. These products support precise therapeutic procedures in cancer care.
- Headquarters Austin, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website endocare.com
- Social LinkedIn X
- Acquired by Varian Medical Systems (Jun 2019)
- Legal Name Endocare Inc
- Total Equity Funding$38.6M (USD)
in 3 rounds
- Latest Funding Round$7M (USD), Series B
May 2007
- InvestorsVarian
& 1 more
- Acquired byVarian Medical Systems
(Jun 2019)
Funding Insights of Endocare
Endocare has successfully raised a total of $38.6M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in May 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $38.6M
- Total Rounds 3
- Last Round Series B — $7M
- First Round $15.6M
(Mar 2005)
- Investors Count 1
All 3 funding rounds of Endocare with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2007 | $7M | Series B | – | – | |
| Oct 2006 | $16M | Series B | – | – | – |
| Mar 2005 | $15.6M | Series B | – | – | – |
2 investors in total: 2 institutional.
Investors in Endocare
Endocare has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Varian and Frazier Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare sector private equity investments are managed by the firm. | 1991 | frazierhealthcare.com | Seattle, United States | |
Varian is focused on developing cancer treatment technologies. | 1948 | varian.com | Palo Alto, United States |
Investor details for Endocare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Endocare
5 dated milestones of Endocare across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Endocare is founded.
- Funding First funding round of $15.6M.
- Funding Latest funding round, Series B, of $7.0M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Varian Medical Systems.
Competitors of Endocare
Endocare has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, Denali Therapeutics and Foundation Medicine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. |
Detailed competitors of Endocare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Endocare (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Endocare
Complete news archive for Endocare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endocare
Endocare was founded in 1996 and raised its 1st funding round 9 years after it was founded.
Endocare is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Endocare is a funded company, having raised a total of $38.6M across 3 funding rounds to date. The company's 1st funding round was a Series B of $15.6M, raised on Mar 2005.
Endocare was founded in 1996 in Austin, United States, and operates within the medical device sector focused on oncology. Diagnostic tools, including an integrated biplane ultrasound for tumor detection via color Doppler visualization, are offered alongside surgical instruments for cryopreservation of cancer cells and planning software. These products support precise therapeutic procedures in cancer care.
Endocare's top competitors include Guardant Health, Foundation Medicine and Denali Therapeutics.
Endocare has 2 investors. Key investors include Varian, and Frazier Healthcare Partners.
Endocare operates through Endocare Inc.
Yes. Endocare was acquired by Varian Medical Systems in June 2019.